These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 31455353)

  • 1.
    D'Alessandro G; Quaglio D; Monaco L; Lauro C; Ghirga F; Ingallina C; De Martino M; Fucile S; Porzia A; Di Castro MA; Bellato F; Mastrotto F; Mori M; Infante P; Turano P; Salmaso S; Caliceti P; Di Marcotullio L; Botta B; Ghini V; Limatola C
    Cell Commun Signal; 2019 Aug; 17(1):108. PubMed ID: 31455353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glabrescione B delivery by self-assembling micelles efficiently inhibits tumor growth in preclinical models of Hedgehog-dependent medulloblastoma.
    Infante P; Malfanti A; Quaglio D; Balducci S; De Martin S; Bufalieri F; Mastrotto F; Basili I; Garofalo M; Lospinoso Severini L; Mori M; Manni I; Moretti M; Nicoletti C; Piaggio G; Caliceti P; Botta B; Ghirga F; Salmaso S; Di Marcotullio L
    Cancer Lett; 2021 Feb; 499():220-231. PubMed ID: 33249196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymeric glabrescione B nanocapsules for passive targeting of Hedgehog-dependent tumor therapy in vitro.
    Ingallina C; Costa PM; Ghirga F; Klippstein R; Wang JT; Berardozzi S; Hodgins N; Infante P; Pollard SM; Botta B; Al-Jamal KT
    Nanomedicine (Lond); 2017 Apr; 12(7):711-728. PubMed ID: 28322108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GPR55 receptor antagonist decreases glycolytic activity in PANC-1 pancreatic cancer cell line and tumor xenografts.
    Bernier M; Catazaro J; Singh NS; Wnorowski A; Boguszewska-Czubara A; Jozwiak K; Powers R; Wainer IW
    Int J Cancer; 2017 Nov; 141(10):2131-2142. PubMed ID: 28741686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aspirin inhibits the SHH/GLI1 signaling pathway and sensitizes malignant glioma cells to temozolomide therapy.
    Ming J; Sun B; Li Z; Lin L; Meng X; Han B; Wang R; Wu P; Li J; Cai J; Jiang C
    Aging (Albany NY); 2017 Apr; 9(4):1233-1247. PubMed ID: 28446712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycolytic inhibition by 3-bromopyruvate increases the cytotoxic effects of chloroethylnitrosoureas to human glioma cells and the DNA interstrand cross-links formation.
    Sun X; Sun G; Huang Y; Zhang S; Tang X; Zhang N; Zhao L; Zhong R; Peng Y
    Toxicology; 2020 Apr; 435():152413. PubMed ID: 32109525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic profiling of human gliomas assessed with NMR.
    Lee JE; Jeun SS; Kim SH; Yoo CY; Baek HM; Yang SH
    J Clin Neurosci; 2019 Oct; 68():275-280. PubMed ID: 31409545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KCa3.1 channel inhibition sensitizes malignant gliomas to temozolomide treatment.
    D'Alessandro G; Grimaldi A; Chece G; Porzia A; Esposito V; Santoro A; Salvati M; Mainiero F; Ragozzino D; Di Angelantonio S; Wulff H; Catalano M; Limatola C
    Oncotarget; 2016 May; 7(21):30781-96. PubMed ID: 27096953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic remodeling of malignant gliomas for enhanced sensitization during radiotherapy: an in vitro study.
    Colen CB; Seraji-Bozorgzad N; Marples B; Galloway MP; Sloan AE; Mathupala SP
    Neurosurgery; 2006 Dec; 59(6):1313-23; discussion 1323-4. PubMed ID: 17277695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolomic signature of brain cancer.
    Pandey R; Caflisch L; Lodi A; Brenner AJ; Tiziani S
    Mol Carcinog; 2017 Nov; 56(11):2355-2371. PubMed ID: 28618012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of oxidative phosphorylation confers resistance against bevacizumab in experimental glioma.
    Eriksson JA; Wanka C; Burger MC; Urban H; Hartel I; von Renesse J; Harter PN; Mittelbronn M; Steinbach JP; Rieger J
    J Neurochem; 2018 Feb; 144(4):421-430. PubMed ID: 29178334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diclofenac inhibits lactate formation and efficiently counteracts local immune suppression in a murine glioma model.
    Chirasani SR; Leukel P; Gottfried E; Hochrein J; Stadler K; Neumann B; Oefner PJ; Gronwald W; Bogdahn U; Hau P; Kreutz M; Grauer OM
    Int J Cancer; 2013 Feb; 132(4):843-53. PubMed ID: 22752934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combinatorial therapy with adenoviral-mediated PTEN and a PI3K inhibitor suppresses malignant glioma cell growth in vitro and in vivo by regulating the PI3K/AKT signaling pathway.
    Nan Y; Guo L; Song Y; Wang L; Yu K; Huang Q; Zhong Y
    J Cancer Res Clin Oncol; 2017 Aug; 143(8):1477-1487. PubMed ID: 28401302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isogambogenic Acid Inhibits the Growth of Glioma Through Activation of the AMPK-mTOR Pathway.
    Zhao W; Peng F; Shu M; Liu H; Hou X; Wang X; Ye J; Zhao B; Wang K; Zhong C; Xue L; Gao M; Liu Y; Zhao S
    Cell Physiol Biochem; 2017; 44(4):1381-1395. PubMed ID: 29186708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NMR metabolomics highlights sphingosine kinase-1 as a new molecular switch in the orchestration of aberrant metabolic phenotype in cancer cells.
    Bernacchioni C; Ghini V; Cencetti F; Japtok L; Donati C; Bruni P; Turano P
    Mol Oncol; 2017 May; 11(5):517-533. PubMed ID: 28258651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined Modulation of Tumor Metabolism by Metformin and Diclofenac in Glioma.
    Gerthofer V; Kreutz M; Renner K; Jachnik B; Dettmer K; Oefner P; Riemenschneider MJ; Proescholdt M; Vollmann-Zwerenz A; Hau P; Seliger C
    Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30200299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lactate turnover in rat glioma measured by in vivo nuclear magnetic resonance spectroscopy.
    Terpstra M; Gruetter R; High WB; Mescher M; DelaBarre L; Merkle H; Garwood M
    Cancer Res; 1998 Nov; 58(22):5083-8. PubMed ID: 9823316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo characterization of brain metabolism by
    Lai M; Vassallo I; Lanz B; Poitry-Yamate C; Hamou MF; Cudalbu C; Gruetter R; Hegi ME
    Int J Cancer; 2018 Jul; 143(1):127-138. PubMed ID: 29417580
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Gao L; Wang KX; Zhang NN; Li JQ; Qin XM; Wang XL
    J Proteome Res; 2018 May; 17(5):1833-1843. PubMed ID: 29589762
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.